This site is intended for health professionals only
The Supervisory Board of IDEA AG today announced that Prof. Cevc has resigned as Chairman of the Vorstand and Chief
Executive officer with immediate effect.
Prof. Cevc and the Board have differing views on the future strategic direction of the company and this course of action was agreed as being in the best interests of all parties. The Board thanks Prof. Cevc for his contribution, commitment and leadership over the years and wishes him every success in the future.
The Supervisory Board is pleased to announce that Gosse B. Bruinsma, M.D. has been appointed as Chairman of the Vorstand and Chief Executive Officer, also with immediate effect. Dr. Bruinsma has a distinguished career of over 25 years in medicine and business, having served as Chairman and Chief Executive Officer in several life sciences companies in the USA and Europe.
Dr. Bruinsma, IDEA´s new CEO, comments: “IDEA has an important scientific heretage and sound scientific and development teams which can be aligned to support this new phase of the Company. I am delighted to lead the Company and exploit the larger potential commercial opportunities that IDEA has.”
Dr. G.J. Blaker, IDEA’s Chairman of the Supervisory Board, adds:
“The Supervisory Board is delighted that Gosse has joined IDEA as CEO and we are confident that his skill set will support the Company during its next phase.”